SCOPUS 정보 검색 플랫폼

Diabetes Technology and Therapeutics

Volumn 10, Issue 4, 2008, Pages 328-329

Torcetrapib as potential treatment of low high-density lipoprotein cholesterol: No longer a pipe dream?

(1) Ahmed, Mohamed H a

a SOUTHAMPTON GENERAL HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; TORCETRAPIB;

ANGINA PECTORIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CORONARY ARTERY DISEASE; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; EXERCISE; FAMILIAL HYPERCHOLESTEROLEMIA; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFECTION; LIPOPROTEIN METABOLISM; MONOTHERAPY; NEOPLASM; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CLINICAL TRIALS AS TOPIC; HUMANS; QUINOLINES;

EID: 50049133540 PISSN: 15209156 EISSN: None Source Type: Journal
DOI: 10.1089/dia.2007.0289 Document Type: Short Survey

Times cited : (1)

References (9)

1
- 33845320131
- Molecular regulation of HDL metabolism and function: Implications for novel therapies
- Rader DJ: Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 2006;116:3090-3100.
- (2006) J Clin Invest , vol.116 , pp. 3090-3100
- Rader, D.J.¹

2
- 14344284525
- Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: A working group report
- Gotto AM Jr: Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation 2001;103:2213-2218.
- (2001) Circulation , vol.103 , pp. 2213-2218
- Gotto Jr, A.M.¹

3
- 34748887666
- Treating to New Targets Investigators: HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
- Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators: HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007;357:1301-1310.
- (2007) N Engl J Med , vol.357 , pp. 1301-1310
- Barter, P.¹ Gotto, A.M.² LaRosa, J.C.³ Maroni, J.⁴ Szarek, M.⁵ Grundy, S.M.⁶ Kastelein, J.J.⁷ Bittner, V.⁸ Fruchart, J.C.⁹

4
- 12144287356
- Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib
- Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ: Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 2004;24:490-497.
- (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 490-497
- Clark, R.W.¹ Sutfin, T.A.² Ruggeri, R.B.³ Willauer, A.T.⁴ Sugarman, E.D.⁵ Magnus-Aryitey, G.⁶ Cosgrove, P.G.⁷ Sand, T.M.⁸ Wester, R.T.⁹ Williams, J.A.¹⁰ Perlman, M.E.¹¹ Bamberger, M.J.¹²

5
- 33846424247
- The failure of torcetrapib: Was it the molecule or the mechanism?
- Tall AR, Yvan-Charvet L, Wang N: The failure of torcetrapib: was it the molecule or the mechanism? Arterioscler Thromb Vasc Biol 2007;27:257-260.
- (2007) Arterioscler Thromb Vasc Biol , vol.27 , pp. 257-260
- Tall, A.R.¹ Yvan-Charvet, L.² Wang, N.³

6
- 34247241088
- Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia
- Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML: Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med 2007;356:1620-1630.
- (2007) N Engl J Med , vol.356 , pp. 1620-1630
- Kastelein, J.J.¹ van Leuven, S.I.² Burgess, L.³ Evans, G.W.⁴ Kuivenhoven, J.A.⁵ Barter, P.J.⁶ Revkin, J.H.⁷ Grobbee, D.E.⁸ Riley, W.A.⁹ Shear, C.L.¹⁰ Duggan, W.T.¹¹ Bots, M.L.¹²

7
- 34047106220
- ILLUSTRATE Investigators: Effect of torcetrapib on the progression of coronary atherosclerosis
- Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM; ILLUSTRATE Investigators: Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007;356:1304-1316.
- (2007) N Engl J Med , vol.356 , pp. 1304-1316
- Nissen, S.E.¹ Tardif, J.C.² Nicholls, S.J.³ Revkin, J.H.⁴ Shear, C.L.⁵ Duggan, W.T.⁶ Ruzyllo, W.⁷ Bachinsky, W.B.⁸ Lasala, G.P.⁹ Tuzcu, E.M.¹⁰

8
- 34548493959
- The association of aldosterone with obesity-related hypertension and the metabolic syndrome
- Vogt B, Bochud M, Burnier M: The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Semin Nephrol 2007;27:529-537.
- (2007) Semin Nephrol , vol.27 , pp. 529-537
- Vogt, B.¹ Bochud, M.² Burnier, M.³

9
- 59349119385
- Metabolic syndrome, diabetes and cardiovascular risk
- Packard CJ, ed, Oxford, UK: Clinical Publishing
- Ahmed MH, Byrne CD: Metabolic syndrome, diabetes and cardiovascular risk. In: Packard CJ, ed. The Year in Lipid Disorders. Oxford, UK: Clinical Publishing, 2007:3-26.
- (2007) The Year in Lipid Disorders , pp. 3-26
- Ahmed, M.H.¹ Byrne, C.D.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.